SEC Form 4 · accession 0001179110-15-014305
ST JUDE MEDICAL, LLC · STJ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel J Starks
Officer — Chairman, CEO & President · Director
Period of report
Oct 28, 2015
Accepted (ET)
Oct 30, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000203077
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 28, 2015 | M | 120,000 | $40.55 | A | 6,232,363 | D | |
| Common StockF2 | Oct 28, 2015 | S | 115,786 | $62.35 | D | 6,116,577 | D | |
| Common StockF3 | Oct 28, 2015 | S | 4,214 | $62.68 | D | 6,112,363 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F4 | $40.55 | Oct 28, 2015 | M | 120,000 | D | Dec 10, 2008 | Dec 10, 2015 | Common Stock | 120,000 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 22, 2014.
- F2The price in Column 4 is a weighted average. The prices actually received ranged from $61.65 to $62.64. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3The price in Column 4 is a weighted average. The prices actually received ranged from $62.65 to $62.76. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F4Fully vested at the time of filing.